FREE SHIPPING ON ORDERS OVER $150

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

$28.05

Quantity
- +
Description

Science 270: 11661170

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

FDA news release

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Inagaki N, Seino Y, Takeda J, Yano H, Yamada Y, Bell GI, et al

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

If you'd like a deeper clinical overview, our resources on what is GLP-1 and what is GLP-1 medication provide further detail

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

The satiety effects diminish

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

Ozempic, meanwhile, is a medication containing semaglutide, which falls under a class of medications known as GLP-1 receptor agonists

glp-1 receptor agonists and cardiovascular outcome trials an update in Heart Failure The Paper of The Month

You may also like

recommand products